Summary of Purpose
Administration of cell-free exosomes derived from mesenchymal stem cell (MSCs) can be sufficient to exert therapeutic effects of intact MSCs after brain injury. In this study we aim to assay the administration of MSC derived exosome enriched by miR-124 on improvemen of disability of patients with acute ischemic strokeRead More →
The following dates are available for this trial. Trial information last updated on 28 December 2017.
|17 Jan 2018||29 Nov 2017||17 Jul 2018||17 Jan 2019||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Masoud Soleimani, Associate